Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients
Status:
COMPLETED
Trial end date:
2023-08-31
Target enrollment:
Participant gender:
Summary
This study aimed to determine the impact of Pentoxifylline on inflammatory biomarkers and the progression of chronic kidney disease in non-diabetic patients.